Reuters: Health
The U.S. Food and Drug Administration approved Blueprint Medicines Corp's oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday.
FDA approves Blueprint's stomach cancer therapy priced at $32,000 per month
FDA approves Blueprint's stomach cancer therapy priced at $32,000 per month
Reuters: Health
The U.S. Food and Drug Administration approved Blueprint Medicines Corp's oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday.
Reuters: Health
The U.S. Food and Drug Administration approved Blueprint Medicines Corp's oral therapy to treat a rare form of cancer that affects the stomach and small intestine, the agency said on Thursday.
Subscribe to:
Post Comments (Atom)
Popular Posts
|
No comments:
Post a Comment